Northern Trust Corp Chemo Centryx, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $351,150 - $820,460	15,839 Added 2.46%	658,607 $34 Million
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $1.33 Million - $2.39 Million	86,824 Added 15.62%	642,768 $15.9 Million
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $758,679 - $1.34 Million	34,144 Added 6.54%	555,944 $13.9 Million
Q4 2021 Feb 08, 2022	SELL	$18.38 - $40.5 $403,955 - $890,109	-21,978 Reduced 4.04%	521,800 $19 Million
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $320,998 - $482,959	-24,355 Reduced 4.29%	543,778 $9.3 Million
Q2 2021 Aug 13, 2021	SELL	$9.59 - $50.88 $5,475 - $29,052	-571 Reduced 0.1%	568,133 $7.61 Million
Q1 2021 May 12, 2021	SELL	$49.53 - $68.4 $1.94 Million - $2.68 Million	-39,192 Reduced 6.45%	568,704 $29.1 Million
Q4 2020 Feb 11, 2021	SELL	$47.25 - $65.16 $684,983 - $944,624	-14,497 Reduced 2.33%	607,896 $37.6 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $683,430 - $909,619	14,745 Added 2.43%	622,393 $34.1 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $3.13 Million - $5.28 Million	81,173 Added 15.42%	607,648 $35 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $319,281 - $495,358	9,755 Added 1.89%	526,475 $21.2 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $87,161 - $506,200	12,799 Added 2.54%	516,720 $20.4 Million
Q3 2019 Nov 13, 2019	BUY	$6.47 - $8.96 $947,971 - $1.31 Million	146,518 Added 41.0%	503,921 $3.42 Million
Q2 2019 Aug 13, 2019	BUY	$8.31 - $14.85 $393,860 - $703,830	47,396 Added 15.29%	357,403 $3.32 Million
Q1 2019 May 13, 2019	BUY	$10.01 - $13.89 $103,953 - $144,247	10,385 Added 3.47%	310,007 $4.31 Million
Q4 2018 Feb 12, 2019	SELL	$9.15 - $12.26 $4,456 - $5,970	-487 Reduced 0.16%	299,622 $3.27 Million
Q3 2018 Nov 14, 2018	BUY	$10.49 - $13.72 $381,238 - $498,625	36,343 Added 13.78%	300,109 $3.79 Million
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $132,898 - $174,945	-12,514 Reduced 4.53%	263,766 $3.47 Million
Q1 2018 May 09, 2018	SELL	$5.9 - $14.99 $542 - $1,379	-92 Reduced 0.03%	276,280 $3.76 Million
Q4 2017 Feb 14, 2018	BUY	$5.53 - $8.42 $2,361 - $3,595	427 Added 0.15%	276,372 $1.64 Million
Q3 2017 Nov 13, 2017	BUY	$6.5 - $10.69 $1.79 Million - $2.95 Million	275,945	275,945 $2.05 Million

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account